• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Repros Therapeutics Inc. (RPRX)

    -NasdaqCM
    7.40 Down 0.03(0.40%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development7,321  6,225  6,107  7,206  
    Selling General and Administrative1,205  1,678  1,277  1,256  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (8,526) (7,903) (7,384) (8,462)
    Income from Continuing Operations
    Total Other Income/Expenses Net1  2  2  3  
    Earnings Before Interest And Taxes(8,525)(7,901)(7,382)(8,459)
    Interest Expense -   -   -   -  
    Income Before Tax(8,525)(7,901)(7,382)(8,459)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(8,525)(7,901)(7,382)(8,459)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (8,525) (7,901) (7,382) (8,459)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (8,525) (7,901) (7,382) (8,459)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.